Consider Ingrezza When Treatment Is Needed for Tardive Dyskinesia

The approval of Ingrezza (in-GREH-zah, valbenazine) will raise questions about how to treat tardive dyskinesia.

Up to 30% of patients on long-term antipsychotics develop tardive dyskinesia. It's usually associated with higher doses, longer duration, and higher-potency typical antipsychotics, such as haloperidol.

But it can also occur with atypical antipsychotics, such as risperidone...and other dopamine blockers, such as metoclopramide.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote